在一线药一个月的成本3000卢布（约合50美元）的国家，在三分之一人每天话费不到1.25美元的国家，在柜台购买药物是许多人都担负不起的选择。因此，德里积极人网，一个艾滋病人信任的网络，打算起诉政府造成生命药短缺的状态，来再次实现免费抗病毒治疗药物的分发。

原文标题：《Drugs shortage in free antiretroviral treatment programs in India is trouble for the poor》

英文原文：

HIV drug shortages in India over the past few months have meant that many people living with HIV (PLHIV) are unable to access antiretroviral treatment (ART) through government run distribution centres. Thousands of PLHIV rely on the free ART provided by India’s National AIDS Control Organization (NACO), however they are facing drug shortfalls that are largely blamed on supply bottlenecks, late payments to pharmaceutical companies and Indian manufacturers boycotting the process. This has made unavailable three HIV medicines – two for treating children and one for adults.

India has the third largest number of people living with HIV (PLHIV) in the world, and accounts for about forty percent of the PLHIV in Asia. Of the 2.1 million PLHIV in India, around 750,000 depend on the free distribution of drugs through government-run centres. Corruption and, dysfunctional supply chain mean that the drugs allocated for free distribution often do not reach those who need it. As a result, people in need of medication have been told to seek out their ART by other means.

In a country where first line ART costs about 3,000 rupees (US$50) for one month’s supply, and one in three people are living on less than US$1.25 a day, buying drugs over the counter is simply not an option many can afford. As such, the Delhi Network of Positive People, a trust that works with HIV/AIDS patients, is planning to file a lawsuit against the government over the shortage of the life-saving drugs in various states, to realize the free distribution ART again.